E2F1 and hepatocellular carcinoma: E2F8 was found to be markedly overexpressed in HCC to facilitate tumor occurrence and development via activation of an E2F1/cyclin D1 signaling pathway to regulate the G1- to S-phase transition of cell cycle progression or transcriptionally suppress CDK1 to induce hepatocyte polyploidization [56].